U.S. Markets closed

Is a Surprise Coming for Itau Unibanco (ITUB) This Earnings Season?

Zacks Equity Research
1 / 2

Is Comtech Telecommunications (CMTL) Stock Outpacing Its Computer and Technology Peers This Year?

Is (CMTL) Outperforming Other Computer and Technology Stocks This Year?

Investors are always looking for stocks that are poised to beat at earnings season and Itau Unibanco Holding S.A. ITUB may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Itau Unibanco is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings—with the most up-to-date information possible—is a pretty good indicator of some favorable trends underneath the surface for ITUB in this report.

Analysts have very recently bumped up their estimates for ITUB, giving the stock a Zacks Earnings ESP of +0.57% heading into earnings season.

Itau Unibanco Holding S.A. Price and EPS Surprise

Itau Unibanco Holding S.A. Price and EPS Surprise | Itau Unibanco Holding S.A. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10 year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that ITUB has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for Itau Unibanco, and that a beat might be in the cards for the upcoming report.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Itau Unibanco Holding S.A. (ITUB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.